Stock screener

KRYS

Conviction 51HealthcareScan · Thu, Sep 24, 2026

Krystal Biotech, Inc. (KRYS) closed at $344.94 (+0.93%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 50, RS Rating 93, -8.8% from its 52-week high, +39.7% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

KRYS$344.94+0.93%
ResistanceSupportVol 14Insider sell
63 bars
8
Vol MA14 316.68K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Krystal Biotech, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.krystalbio.com ↗
Price344.94
Change+0.93%
Gap-0.85%
Rel volume—
Avg volume285.52K
Avg $ vol99.18M
SMA 20349.16
SMA 50343.25
SMA 200298.60
Price vs 50+0.49%
Price vs 200+15.52%
MA stackbullish
50/200 cross—
Supertrenddown · 367.54
RSI (14)50
MACD hist-0.79
MACD cross—
Stoch %K / %D33 / 34
ADX (14)13
+DI / −DI20 / 19
RSI divergence—
MACD divergence—
ATR %3.37%
ADR %3.08%
52w high378.15
52w low161.15
From 52w high-8.78%
Above 52w low+114.05%
New 52w highNo
SqueezeOff
Bollinger width12.47%
%B0.40
Donchian pos31.66%
Donchian high373.31
Donchian low331.79
AVWAP (52w high)342.53
vs AVWAP high+0.70%
AVWAP (52w low)282.69
vs AVWAP low+22.02%
OBV trendDown
Chaikin MF (20)-0.09
Today vs 20d—
Avg vol (14d)316.68K
Avg vol (20d)285.52K
Avg $ vol (20d)99.18M
Market cap10.21B
RS Rating93 / 99
RS 3m (vs SPY)-8.66%
RS 6m (vs SPY)+18.48%
RS line new highNo
Trend template7/8
Technical rank78.5
1 week+1.83%
1 month-3.16%
3 months-4.16%
6 months+35.30%
1 year+109.09%
YTD+39.70%
P/E49.85
P/B7.51
P/S26.24
P/FCF54.04
EPS6.84
Div yield—
ROE15.07%
ROA13.65%
Debt/Eq0.00
Current8.32
EV/EBITDA59.19
Gross margin—
Net margin52.64%
Rev growth33.94%
EPS growth129.74%
Price target409.29
Target upside18.66%
Analyst ratingBuy
Institutional112.82%
Ent. value9.79B
Revenue119.22M
Net income54.77M
Gross profit—
Free cash flow188.91M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out29.48M
Employees295
ListedWed, Sep 20, 2017
Free float23.93M
Float %81.3%
Short interest3.35M
Days to cover15.3d
Short volume87.5%
Squeeze score73 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.79 vs $1.70
Last surprise+5.3% beat
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank78.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance368.57
Support308.82
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KRYS

All disclosures →
No recent disclosed trades by Congress in KRYS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KRYS · open-market 9 sells

InsiderSideShares
ROSSI DINO A
Director · Common Stock · 2026-08-14
Gift3.69K
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell341
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell2.29K
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell5.23K
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell1.69K
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell7.43K
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell4.9K
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell3.1K
ROSSI DINO A
Director · Common Stock · 2026-08-14
Sell40
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell12.73K

SEC filings

EDGAR filings in KRYS · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.